Invitrogen™ Bermekimab Humanized Recombinant Human Monoclonal Antibody

Human Recombinant Monoclonal Antibody

Supplier: Invitrogen™ MA542060

Numéro de catalogue. PIMA542060

$985.83 / chaque

Quantité

Description

Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.

Bermekimab is under investigation in clinical trial NCT01384630 (Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis).

Spécifications

Identifiants chimiques

Antigen	Bermekimab Humanized
Content And Storage	-20°C, Avoid Freeze/Thaw Cycles
Classification	Recombinant Monoclonal
Form	Liquid
Isotype	IgG1 κ
Target Species	Human
Gene Alias	MABp1; Xilonix
Primary or Secondary	Primary
Purification Method	Protein A

Concentration	2.34 mg/mL
Applications	ELISA, SDS-Page
Conjugate	Unconjugated
Host Species	Human
Regulatory Status	RUO
Formulation	PBS with no preservative; pH 7.5
Immunogen	Human IL1A.
Product Type	Antibody

Spécifications

Antigen	Bermekimab Humanized
Classification	Recombinant Monoclonal
Conjugate	Unconjugated
Gene Alias	MABp1; Xilonix
Immunogen	Human IL1A.
Quantity	100 μg
Primary or Secondary	Primary
Content And Storage	-20°C, Avoid Freeze/Thaw Cycles
Form	Liquid
Target Molecule	Chemical

Applications	ELISA, SDS-Page
Concentration	2.34 mg/mL
Formulation	PBS with no preservative; pH 7.5
Host Species	Human
Purification Method	Protein A
Regulatory Status	RUO
Target Species	Human
Product Type	Antibody
Isotype	IgG1 κ

missing translation for 'recommendations'

Invitrogen™ Bermekimab Humanized Recombinant Human Monoclonal Antibody

Description

Identifiants chimiques

Spécifications

missing translation for 'recommendations'

Documents

Promotions